Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Cancer Medicine|September 17, 2025
Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective StudyKazumasa Yamamoto, Hidekazu Hirano, Toshiharu Hirose, et al.
Diseases of the Colon and Rectum|August 16, 2021
Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression AnalysisTaro Tanabe, Dai Shida, Narikazu Boku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 24, 2010
[Introducing multidisciplinary team practice--through our experience gained from visiting MD Anderson Cancer Center]Naoko Sugiyama, Atsuo Takashima, Hironobu Hashimoto, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 29, 2018
Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted ChemotherapyDai Shida, Narikazu Boku, Taro Tanabe, et al.
Annals of Surgical Oncology|June 9, 2016
Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score AnalysisDai Shida, Tetsuya Hamaguchi, Hiroki Ochiai, et al.
Japanese Journal of Clinical Oncology|July 16, 2010
Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805)Atsuo Takashima, Chigusa Morizane, Hiroshi Ishii, et al.
The Oncologist|May 8, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
The Oncologist|April 17, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
Biomedical Optics Express|August 28, 2019
Optical characteristics of human skin with hyperpigmentation caused by fluorinated pyrimidine anticancer agentTakahiro Kono, Nobuaki Imanishi, Keiko Nozawa, et al.
Diseases of the Colon and Rectum|October 8, 2021
Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal CancerYuya Nakamura, Dai Shida, Narikazu Boku, et al.
Pageof 19